Dekker, Linda P. http://orcid.org/0000-0001-5720-3296
van der Vegt, Esther J. M.
Louwerse, Anneke
Visser, Kirsten
van der Ende, Jan
Maras, Athanasios
Verhulst, Frank C.
Greaves-Lord, Kirstin
Funding for this research was provided by:
Stichting Vrienden van het Sophia (617)
Academic Workplace Autism (ZonMw grant: 639003101)
Yulius (-)
Article History
Received: 12 October 2020
Revised: 30 September 2022
Accepted: 30 September 2022
First Online: 14 October 2022
Declarations
:
: L.P. Dekker and K. Greaves-Lord are the developers of the TTI, for this they do not receive remuneration. K. Greaves-Lord is the second author on the Dutch ADOS-2 manual, for which Yulius receives remuneration. F.C. Verhulst is former head of the department of Child and Adolescent Psychiatry at Erasmus MC, which publishes ASEBA materials and from which he receives remuneration. A. Maras has been a consultant to/member of advisory board of/and/or speaker for Janssen Cilag BV, Eli Lilly, Shire. He is not an employee or a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, and royalties. E. van der Vegt, A. Louwerse, K. Visser, and J. van der Ende declare that they do not have conflict of interest.
: All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the medical ethical commission of the Erasmus Medical Center, Rotterdam (MEC-2013–040).
: Written informed consent is obtained from all participating adolescents and their parents.